JPRN-UMIN000007026招募中未知
Efficacy IOP lowering and safety of Travoprost Ophthalmic Solution in Normal Tension Glaucoma patients. - Efficacy IOP lowering and safety of Travoprost Ophthalmic Solution in Normal Tension Glaucoma patients.
I.CHANGE study group0 个研究点目标入组 100 人开始时间: 2012年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Complications with chronic or recurrent uveitis, scleritis, or corneal herpes. 2.History of ocular trauma or intraocular conventional surgery or laser ocular surgery in the study eye within 3 months before baseline examinations. 3.Any abnormality preventing reliable applanation tonometer in the study eye. 4.Known medical history of allergic to PGA. 5.Patients using an IOP-lowering drug other than those to be used in the study. 6.Patients using systemic administration of an oral CAI (Diamox, etc.) 7.Patient having serious eyes complications 8.Women who are pregnant or lactating. 9.Patients who are judged to be inappropriate for participation in the study for other reason by the doctor in charge.
研究者
相似试验
已完成
不适用
Investigation of IOP reduction efficacy of Travoprost Ophthalmic Solution in patients with normal tension glaucomanormal tension glaucomaJPRN-UMIN000011621Alcon Japan Ltd34
已完成
2 期
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00670033Alcon Research158
已完成
不适用
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma or Ocular Hypertensio-H40H40PER-028-02ALCON RESEARCH LTD.,
已完成
3 期
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)Glaucoma, Open-AngleOcular HypertensionNCT00051142Alcon Research
进行中（未招募）
不适用
Hypotonic efficacy and tollerability of Travoprost in patient with openangle primary glaucoma and/or ocular hypertension, not controlled withdorzolamide + timolol treatment in fixed association, or intollerantto itReducing high intraocular pressure in patient with ocular hypertension or open-angle glaucomaMedDRA version: 6.1Level: PTClassification code 10030348EUCTR2005-001786-34-ITALCON ITALIA80